Cheap Indian Generic Drugs are Not Fake: WHO

The World Health Organization (WHO) has denied reports saying that more than one-third of cheap generic medicines available in the Indian market are fake.

The World Health Organization (WHO) has denied reports saying that more than one-third of cheap generic medicines available in the Indian market are fake, according to a senior official in the union health ministry.

A senior official in the union health ministry Friday said the World Health Organization's (WHO) India Representative Nata Menabde had written to the ministry denying that any report from WHO claimed that a third of cheap generic drugs produced in India were counterfeit.

Banned Drugs | Drugs Banned in India | List of Banned Drugs
Several drugs are either banned or withdrawn after introduction in the market.

The World Health Organization's (WHO) India Representative Nata Menabde had written to the ministry denying the reports appeared in the media quoting WHO and claiming that the bulk of cheap drugs manufactured in India were counterfeit.

Arun J Panda, joint secretary in the ministry of health said: "There have been reports recently that say the bulk of medicines produced in India are counterfeit. We disagree."

"The reports also quoted WHO, so I wrote to WHO's country representative, who wrote back to say that they had never said anything to that effect," Panda said.

Drug Toxicity - Prescriptions Pharmacokinetics Medication Information Ratings Categorizations Therapeutic
Drug toxicity is an adverse reaction of the body towards a drug that results as a side effect of a drug, reaction to a drug or drug abuse.

Panda was speaking at a seminar on the pharmaceuticals industry organized by the PHD Chamber of Commerce. He said the letter from WHO would be put up on the ministry's website.

Panda, however, said that a small quantity of sub-standard, and very small quantity of spurious drugs were found in surveys conducted by the government.

Sound Alike / Look Alike (SALA or LASA) Drugs
Medication errors due to drug names that sound similar or appear similar with few examples.

"We export drugs worth US$ 13 billion to 230 countries. During various surveys, we have come across four to five percent substandard drugs, and some 0.4 percent of spurious drugs," he said.

The official also said that often the standard of the drugs is affected by poor storage.

Speaking at the conference, L.C. Goyal, additional secretary in the cabinet secretariat, emphasized that production of generic medicine was needed to meet the target of providing free medicines as planned by the government.

Source-IANS